Share Name Share Symbol Market Type Share ISIN Share Description
Premaitha LSE:NIPT London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.375p +4.84% 8.125p 7.75p 8.50p 8.125p 7.50p 7.75p 901,083 15:56:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 2.5 -12.1 6.0 1.4 18.54

Premaitha Share Discussion Threads

Showing 4776 to 4798 of 4800 messages
Chat Pages: 192  191  190  189  188  187  186  185  184  183  182  181  Older
DateSubjectAuthorDiscuss
20/9/2017
13:40
Premaitha almost a goner ? Not long ago we had Yourgene and recently Premaitha were advertising for personnel. In "reality" hardly the actions of a "gonner" . . . .
gooosed
20/9/2017
12:30
let's let the judge make that decision eh!? Even if it's against it still won't be curtains as appeals will take forever and by then UK/Europe will only be a fraction of the revenue stream and Illumina can keep it ha ha! That's why the current efforts are all about de-risking!! UK/Europe are not the best gig in town as they are very very slow on the uptake and other parts of the world are much better and quicker to commit. In any case Prem will win...sorted!!
hjb1
20/9/2017
12:11
seen this hundreds of times on AIM - holders like myself giving it the glass half full chat but in reality the company is all but a gonner
the monkster
20/9/2017
11:33
think yourself lucky, some would have bought at 30p
hjb1
20/9/2017
11:15
I'm 53% down when O when will this turnaround?
christopher logsdon
20/9/2017
08:30
Reminder hTTp://www.bio-itworld.com/tecan/advances-in-non-invasive-prenatal-screening/?utm_campaign=PB%20::%20Prenatal%20Screening%20::%20CHI%20Webinar&utm_content=59778850&utm_medium=social&utm_source=twitter
gooosed
19/9/2017
10:17
Illumina and Europe becoming more and more irrelevant
timojelly
19/9/2017
09:26
Let's hope we make a breakthrough into China.
gooosed
19/9/2017
07:54
Not for long.
small crow
19/9/2017
07:14
Good news again but litigation issues will cloud over it.
timojelly
19/9/2017
07:07
Good news.
small crow
13/9/2017
06:29
Cool video.
timojelly
12/9/2017
21:37
hTTps://vimeo.com/232488311
hjb1
09/9/2017
22:34
Cenata..Germany interesting to see they are sending the test out getting around the patent as was explained to me that Prem could do the same with Yourgen; Have I got that right? Cenata and the company Roche have also been sued by the patent holders. A judgment by District Court in Mannheim is awaited. At the hearing before that court, the judge made it clear that the performance of the Harmony® Test in a patent-free country abroad would not infringe the patent in Germany. Cenata will, therefore, have the Harmony® Test performed by the laboratory Medirex in Slovakia until March 2018. Slovakia is a member of the European Union. This means that the high-quality Harmony® Test can be offered in the usual quality and with short turnaround times. The Medirex laboratory is the largest laboratory in Slovakia and, additionally, accredited in accordance with ISO 9001 and 15189 as well as CAP/CLIA. It is certified by Ariosa and Roche Diagnostics and licensed for the performance of the Harmony® Test. Thus, it is guaranteed that the Harmony® Test at Medirex is performed in accordance with the same high quality standards as is the case at Cenata. For offering pregnant patients the Harmony® Test, it is necessary to use, with immediate effect, the new request form, where the patient consents to the performance of the test by the Medirex laboratory. Other than the use of this request form, nothing changes: The high quality, the short throughput times of the Harmony® Tests and the price remain unchanged. The test results will also continue to be validated by the physicians of Cenata.
hjb1
08/9/2017
09:31
Getting close to a year low
dave444
07/9/2017
21:34
Doesn't help their cause with EU regulators...
small crow
07/9/2017
21:05
For me this is a sign of desperation from illumina
kaka47
07/9/2017
20:08
Smacks of desperation, and hopefully will be seen as such.
jonnysquare
07/9/2017
19:44
Not a holder but looks like premaitha are going to win the first case from this new action. Question is, can the business cope with these continuous bully boy tactics?
pugg1ey
07/9/2017
19:07
Illumina bullies are at it again. They're not afraid, they're simply ruthless. Will they ever give up the fight? Premaitha once had such great promise but now I'm not so sure. I'll be watching from the sidelines as an ex-holder here, curious to see how this turns out for the minnow vs the Goliath.
bdog51
07/9/2017
18:04
Unbelievable they must have known. On borrowed time this now. Not big enough to ride out these Writs.Not looking good at moment goes from bad to worse
thinkbig?
07/9/2017
15:57
Bloody crooks
timojelly
07/9/2017
15:25
defending all these claims cannot be helping the capital of the company. They may win the cases in the long run but how are they able to afford to defend these claims without it causing more dilution to the share price.
twodegrees
Chat Pages: 192  191  190  189  188  187  186  185  184  183  182  181  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170921 16:06:25